Periostin in allergic inflammation

Allergology International

Volumn 63, Issue 2, 2014, Pages 143-151

  Izuhara, Kenji ^a   Arima, Kazuhiko ^a   Ohta, Shoichiro ^b   Suzuki, Shoichi ^a   Inamitsu, Masako ^a   Yamamoto, Ken Ichi ^a  

^a Division of Medical Biochemistry   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Allergy; Atopic dermatitis; Bronchial asthma; Inflammation; Periostin

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LEBRIKIZUMAB; NEUTRALIZING ANTIBODY; OMALIZUMAB; THYMIC STROMAL LYMPHOPOIETIN; TRANSCRIPTION FACTOR RUNX2; ANTIALLERGIC AGENT; AUTACOID; CELL ADHESION MOLECULE; POSTN PROTEIN, HUMAN;

ALLERGIC DISEASE; ALLERGIC INFLAMMATION; ALLERGY; ASTHMA; CELL ACTIVATION; CELL SURFACE; DIABETIC RETINOPATHY; DNA MICROARRAY; FIBROBLAST; FIBROSIS; GRANULATION TISSUE; IMMUNE RESPONSE; INFLAMMATION; KERATINOCYTE; LUNG FIBROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCLERODERMA; SKIN ALLERGY; SKIN INJURY; TISSUE STRUCTURE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; GENETICS; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTI-ALLERGIC AGENTS; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; HUMANS; HYPERSENSITIVITY; INFLAMMATION; INFLAMMATION MEDIATORS;

EID: 84902000087     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.13-RAI-0663     Document Type: Review

References (69)

1. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell 2010;140:771-6.
2. Locksley RM. Asthma and allergic inflammation. Cell 2010;140:777-83.
3. Oyoshi MK, He R, Kumar L, Yoon J, Geha RS. Cellular and molecular mechanisms in atopic dermatitis. Adv Immunol 2009;102:135-226.
4. Masuoka M, Shiraishi H, Ohta S et al. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest 2012;122:2590-600.
5. Shiraishi H, Masuoka M, Ohta S et al. Periostin contributes to the pathogenesis of atopic dermatitis by inducing TSLP production from keratinocytes. Allergol Int 2012; 61:563-72.
6. Conway SJ, Izuhara K, Kudo Y et al. The role of periostin in tissue remodeling across health and disease. Cell Mol Life Sci. Epub 2013 Oct 22.
7. Takayama G, Arima K, Kanaji T et al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol 2006;118:98-104.
8. Kii I, Nishiyama T, Li M et al. Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chem2010;285: 2028-39.
9. Norris RA, Damon B, Mironov V et al. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem 2007;101:695-711.
10. Maruhashi T, Kii I, Saito M, Kudo A. Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase. J Biol Chem2010;285:13294-303.
11. Takeshita S, Kikuno R, Tezuka K, Amann E. Osteoblastspecific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J 1993;294:271-8.
12. Kudo A. Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the cell. Cell Mol Life Sci 2011;68:3201-7.
13. Markwald RR, Norris RA, Moreno-Rodriguez R, Levine RA. Developmental basis of adult cardiovascular diseases: valvular heart diseases. Ann N Y Acad Sci 2010;1188: 177-83.
14. Nishiyama T, Kii I, Kashima TG et al. Delayed reepithelialization in periostin-deficient mice during cutaneous wound healing. PLoS One 2011;6:e18410.
15. Ontsuka K, Kotobuki Y, Shiraishi H et al. Periostin, a matricellular protein, accelerates cutaneous wound repair by activating dermal fibroblasts. Exp Dermatol 2012;21:331-6.
16. Elliott CG, Wang J, Guo X et al. Periostin modulates myofibroblast differentiation during full-thickness cutaneous wound repair. J Cell Sci 2012;125:121-32.
17. Norris RA, Moreno-Rodriguez R, Hoffman S, Markwald RR. The many facets of the matricelluar protein periostin during cardiac development, remodeling, and pathophysiology. J Cell Commun Signal 2009;3:275-86.
18. Hamilton DW. Functional role of periostin in development and wound repair: implications for connective tissue disease. J Cell Commun Signal 2008;2:9-17.
19. Butcher JT, Norris RA, Hoffman S, Mjaatvedt CH, Markwald RR. Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev Biol 2007; 302:256-66.
20. Kuhn B, del Monte F, Hajjar RJ et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med 2007;13:962-9.
21. Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD. Periostin secreted by epithelial ovarian carcinoma is a ligand for iVV3 and aVV5 integrins and promotes cell motility. Cancer Res 2002;62:5358-64.
22. Baril P, Gangeswaran R, Mahon PC et al. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the c4 integrin and the PI3k pathway. Oncogene 2007;26:2082-94.
23. Johansson MW, Annis DS, Mosher DF. MM2 integrinmediated adhesion and motility of IL-5-stimulated eosinophils on periostin. Am J Respir Cell Mol Biol 2013;48:503-10.
24. Shimazaki M, Nakamura K, Kii I et al. Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med 2008;205:295-303.
25. Yang L, Serada S, Fujimoto M et al. Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma. PLoS One 2012;7:e41994.
26. Bao S, Ouyang G, Bai X et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 2004;5:329-39.
27. Izuhara K, Arima K, Kanaji S, Ohta S, Kanaji T. IL-13: a promising therapeutic target for bronchial asthma. Curr Med Chem 2006;13:2291-8.
28. Izuhara K, Ohta S, Shiraishi H, Suzuki S. Interleukin 4, interleukin 13, and interleukin 9. In: Izuhara K, Holgate ST, Wills-Karp M (eds). Inflammation and Allergy Drug Design. London: Wiley-Blackwell, 2011;175-85.
29. Kuperman DA, Huang X, Koth LL et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 2002;8:885-9.
30. Yuyama N, Davies DE, Akaiwa M et al. Analysis of novel disease-related genes in bronchial asthma. Cytokine 2002; 19:287-96.
31. Hayashi N, Yoshimoto T, Izuhara K, Matsui K, Tanaka T, Nakanishi K. T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-bband IL-13 production. Proc Natl Acad Sci U S A 2007;104:14765-70.
32. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; 1:520-4.
33. Laitinen A, Altraja A, Kampe M, Linden M, Virtanen I, Laitinen LA. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 1997;156:951-8.
34. Woodruff PG, Boushey HA, Dolganov GM et al. Genomewide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A 2007;104:15858-63.
35. Woodruff PG, Modrek B, Choy DF et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009;180:388-95.
36. Sehra S, Yao W, Nguyen ET et al. Periostin regulates goblet cell metaplasia in a model of allergic airway inflammation. J Immunol 2011;186:4959-66.
37. Gordon ED, Sidhu SS, Wang ZE et al. A protective role for periostin and TGF-ffin IgE-mediated allergy and airway hyperresponsiveness. Clin Exp Allergy 2012;42:144-55.
38. Ohta N, Kurakami K, Ishida A et al. Clinical and pathological characteristics of IgG4-related sclerosing sialadenitis. Laryngoscope 2012;122:572-7.
39. Nishizawa H, Matsubara A, Nakagawa T et al. The role of periostin in eosinophilic otitis media. Acta Otolaryngol 2012;132:838-44.
40. Ishida A, Ohta N, Suzuki Y et al. Expression of pendrin and periostin in allergic rhinitis and chronic rhinosinusitis. Allergol Int 2012;61:589-95.
41. Yamaguchi Y. Periostin in skin tissue and skin-related diseases. Allergol Int 2014;63:161-70.
42. Ohta N, Ishida A, Kurakami K et al. Expressions and roles of periostin in otolaryngological diseases. Allergol Int 2014;63:171-80.
43. Okamoto M, Hoshino T, Kitasato Y et al. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J 2011;37:1119-27.
44. Uchida M, Shiraishi H, Ohta S et al. Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis. Am J Respir Cell Mol Biol 2012;46: 677-86.
45. Yamaguchi Y, Ono J, Masuoka M et al. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis. Br J Dermatol 2013;168: 717-25.
46. Yoshida S, Ishikawa K, Asato R et al. Increased expression of periostin in vitreous and fibrovascular membranes obtained from patients with proliferative diabetic retinopa thy. Invest Ophthalmol Vis Sci 2011;52:5670-8.
47. Ishikawa K, Yoshida S, Nakao S et al. Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy. FASEB J 2014;28:131-42.
48. Oku E, Kanaji T, Takata Y et al. Periostin and bone marrow fibrosis. Int J Hematol 2008;88:57-63.
49. Ruan K, Bao S, Ouyang G. The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci 2009;66:2219-30.
50. Fujimoto K, Kawaguchi T, Nakashima O et al. Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma. Oncol Rep 2011;25:1211-6.
51. Horiuchi K, Amizuka N, Takeshita S et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 1999;14:1239-49.
52. Norris RA, Potts JD, Yost MJ et al. Periostin promotes a fibroblastic lineage pathway in atrioventricular valve progenitor cells. Dev Dyn 2009;238:1052-63.
53. Li P, Oparil S, Feng W, Chen YF. Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells. J Appl Physiol 2004;97:1550-8.
54. Lindner V, Wang Q, Conley BA, Friesel RE, Vary CP. Vascular injury induces expression of periostin: implications for vascular cell differentiation and migration. Arterioscler Thromb Vasc Biol 2005;25:77-83.
55. Li G, Oparil S, Sanders JM et al. Phosphatidylinositol-3-kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro. Atherosclerosis 2006;188:292-300.
56. Taniguchi K, Arima K, Masuoka M et al. Periostin controls keratinocyte proliferation and differentiation by interacting with the paracrine IL-1w/IL-6 loop. J Invest Dermatol 2013. DOI: 10.1038/jid.2013.500.
57. Blanchard C, Mingler MK, McBride M et al. Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol 2008;1:289-96.
58. Jia G, Erickson RW, Choy DF et al. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol 2012;130:647-54.
59. Corren J, Lemanske RF, Hanania NA et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011;365: 1088-98.
60. Hanania NA, Wenzel S, Rosen K et al. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med 2013;187:804-11.
61. Adcock IM, Lane SJ. Corticosteroid-insensitive asthma: molecular mechanisms. J Endocrinol 2003;178:347-55.
62. Sorkness RL, Bleecker ER, Busse WW et al. Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol 2008;104:394-403.
63. Kanemitsu Y, Matsumoto H, Izuhara K et al. Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids. J Allergy Clin Immunol 2013;132:305-12.
64. Kato G, Takahashi K, Izuhara K, Komiya K, Kimura S, Hayashi S. Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study. Biomark Insights 2013;8:97-105.
65. Matsumoto H. Serum periostin: a novel biomarker for asthma management. Allergol Int 2014;63:153-60.
66. Orecchia P, Conte R, Balza E et al. Identification of a novel cell binding site of periostin involved in tumour growth. Eur J Cancer 2011;47:2221-9.
67. Naik PK, Bozyk PD, Bentley JK et al. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2012;303:L1046-56.
68. Erkan M, Kleeff J, Gorbachevski A et al. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology 2007;132:1447-64.
69. Sun C, Zhao X, Xu K et al. Periostin: a promising target of therapeutical intervention for prostate cancer. J Transl Med 2011;9:99.